NO
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
64.868
Exchange
OOTC - OTC
3.122
Last period Financial Leverage ,DKK
41%
Financial Leverage has increased in 5 years
What is Financial Leverage ?
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
See also Novo Nordisk
Company Analysis
NONOF valuation, rating, competitors, insights and company profile
Eyestock Rating
NONOF financial analysis by Eyestock methodology
Valuation
NONOF valuation using historical relative method
Statements
NONOF Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NONOF dividend yield and annual dividend
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
Novo Nordisk`s Financial Leverage for the last twelve months ended 2024-06-30 is 3.122
